These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30978487)

  • 1. Encapsulation and release of doxycycline from electrospray-generated PLGA microspheres: Effect of polymer end groups.
    Wang J; Helder L; Shao J; Jansen JA; Yang M; Yang F
    Int J Pharm; 2019 Jun; 564():1-9. PubMed ID: 30978487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the release profile of doxycycline by PLGA microspheres adjunct to non-surgical periodontal therapy.
    Moura LA; Ribeiro FV; Aiello TB; Duek EA; Sallum EA; Nociti Junior FH; Casati MZ; Sallum AW
    J Biomater Sci Polym Ed; 2015; 26(10):573-84. PubMed ID: 25917501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel and etoposide-loaded Poly (lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for dual drug delivery.
    Zhang M; Tang Y; Zhu Z; Zhao H; Yao J; Sun D
    J Biomater Sci Polym Ed; 2018 Nov; 29(16):1949-1963. PubMed ID: 29920151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres.
    Li S; Shi X; Xu B; Wang J; Li P; Wang X; Lou J; Li Z; Yang C; Li S; Zhen P
    J Biomater Appl; 2022 Apr; 36(9):1676-1688. PubMed ID: 35015589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres.
    Qiao Z; Yuan Z; Zhang W; Wei D; Hu N
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):790-798. PubMed ID: 30892092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of PLGA molecular weight differences on risperidone release from microspheres.
    Kohno M; Andhariya JV; Wan B; Bao Q; Rothstein S; Hezel M; Wang Y; Burgess DJ
    Int J Pharm; 2020 May; 582():119339. PubMed ID: 32305366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly[lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection.
    Hsu MY; Huang YT; Weng CJ; Chen CM; Su YF; Chu SY; Tseng JH; Wu RC; Liu SJ
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110937. PubMed ID: 32155454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
    Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules.
    Abulateefeh SR; Alkawareek MY; Alkilany AM
    Int J Pharm; 2019 Mar; 558():291-298. PubMed ID: 30641178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
    Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.
    Mallardé D; Boutignon F; Moine F; Barré E; David S; Touchet H; Ferruti P; Deghenghi R
    Int J Pharm; 2003 Aug; 261(1-2):69-80. PubMed ID: 12878396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tunable and injectable local drug delivery system for personalized periodontal application.
    Wang B; Wang J; Shao J; Kouwer PHJ; Bronkhorst EM; Jansen JA; Walboomers XF; Yang F
    J Control Release; 2020 Aug; 324():134-145. PubMed ID: 32387552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Activity of 3D-Printed Poly(ε-Caprolactone) (PCL) Composite Scaffolds Presenting Vancomycin-Loaded Polylactic Acid-Glycolic Acid (PLGA) Microspheres.
    Zhou Z; Yao Q; Li L; Zhang X; Wei B; Yuan L; Wang L
    Med Sci Monit; 2018 Sep; 24():6934-6945. PubMed ID: 30269152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified hydrophobic ion-pairing complex strategy for long-term peptide delivery with high drug encapsulation and reduced burst release from PLGA microspheres.
    Liu J; Xu Y; Liu Z; Ren H; Meng Z; Liu K; Liu Z; Yong J; Wang Y; Li X
    Eur J Pharm Biopharm; 2019 Nov; 144():217-229. PubMed ID: 31563632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections.
    Yang C; Plackett D; Needham D; Burt HM
    Pharm Res; 2009 Jul; 26(7):1644-56. PubMed ID: 19384471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-by-Design Based Development of Doxycycline Hyclate-Loaded Polymeric Microspheres for Prolonged Drug Release.
    Longre S; Rana D; Rangra S; Jindal AB; Salave S; Vitore J; Benival D
    AAPS PharmSciTech; 2024 Feb; 25(3):49. PubMed ID: 38424393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.